Kondo Hiromi, Ito Shin, Hatazaki Kyoko, Horie Kengo, Nakane Keita, Mizutani Kosuke, Tsuchiya Tomohiro, Yasuda Mitsuru, Yokoi Shigeaki, Nakano Masahiro, Deguchi Takashi
Department of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu 501-1194, Japan.
iClinic, 5-9-6 Naga-machi, Taihaku-ku, Sendai, Miyagi 982-0011, Japan.
J Infect Chemother. 2018 Mar;24(3):232-235. doi: 10.1016/j.jiac.2017.10.013. Epub 2017 Nov 11.
Of 73 clinical strains of Haemophilus influenzae isolated from the urethra of men with urogenital infections, we enrolled 6 strains (8.2%) with levofloxacin (LVFX) minimum inhibitory concentrations (MICs) of ≥0.03 μg/ml in this study. All the strains were isolated from non-gonococcal urethritis (NGU). We amplified the quinolone resistance-determining region of the gyrA gene and the analogous region of the parC gene from bacterial DNAs by PCR and sequenced the PCR products. Two strains with a LVFX MIC of 0.03 μg/ml had an amino acid change of Asp88 to Gly in GyrA. One with a LVFX MIC of 0.06 μg/ml had a change of Asp88 to Tyr in GyrA. Two with respective LVFX MICs of 0.12 and 0.25 μg/ml had a change of Ser84 to Leu in GyrA. One with a LVFX MIC of 1 μg/ml had changes of Ser84 to Leu in GyrA and of Ser84 to Ile in ParC. Multilocus sequence typing showed two strains with a change of Asp88 to Gly in GyrA had the same sequence type, but the others had sequence types different from each other. Single amino acid changes in GyrA alone or single changes in both GyrA and ParC could contribute to decreased susceptibility to fluoroquinolones in H. influenzae isolates from NGU. Most of the isolates with GyrA and/or ParC alterations would be multiclonal. The prevalence of such isolates would be relatively low, and they would still be susceptible to fluoroquinolones commonly prescribed for treatment of NGU.
在从患有泌尿生殖系统感染的男性尿道中分离出的73株流感嗜血杆菌临床菌株中,我们选取了6株(8.2%)左氧氟沙星(LVFX)最低抑菌浓度(MIC)≥0.03 μg/ml的菌株进行本研究。所有菌株均从非淋菌性尿道炎(NGU)中分离得到。我们通过聚合酶链反应(PCR)从细菌DNA中扩增了gyrA基因的喹诺酮耐药决定区和parC基因的类似区域,并对PCR产物进行了测序。两株LVFX MIC为0.03 μg/ml的菌株在GyrA中发生了Asp88到Gly的氨基酸变化。一株LVFX MIC为0.06 μg/ml的菌株在GyrA中发生了Asp88到Tyr的变化。两株LVFX MIC分别为0.12和0.25 μg/ml的菌株在GyrA中发生了Ser84到Leu的变化。一株LVFX MIC为1 μg/ml的菌株在GyrA中发生了Ser84到Leu的变化,在ParC中发生了Ser84到Ile的变化。多位点序列分型显示,两株在GyrA中发生Asp88到Gly变化的菌株具有相同的序列类型,但其他菌株的序列类型彼此不同。单独的GyrA单氨基酸变化或GyrA和ParC两者的单变化都可能导致从NGU分离出的流感嗜血杆菌对氟喹诺酮类药物的敏感性降低。大多数具有GyrA和/或ParC改变的分离株将是多克隆的。此类分离株的流行率相对较低,并且它们对通常用于治疗NGU的氟喹诺酮类药物仍敏感。